Webinar
Achieving Launch Excellence within the Obesity Market
calendar

November 18, 2024

Calendar
clock

10:00am

GMT

Register

View all IQVIA events

The market for prescription anti-obesity medications (AOMs) is the most significant new pharmaceutical market in decades. In the next few years, the already spectacular growth of this market will be accelerated by new launches, including oral agents, development of both the out of pocket and the reimbursed markets, outcomes trials showing new benefits for current agents, and intense competition.

IQVIA will provide a forward looking, global guide to understanding and navigating this fast-moving environment, identifying the key levers and issues which will shape the market in the next five years.

We’ll explore:

  • Current and future competitive environment- with 149 new assets, 50+ MoAs and 70+ companies behind them, the obesity market will be fast moving and intensely competitive – what might the winners of the future look like?
  • What do Patient and Healthcare Professionals think about the challenges of obesity treatment and current AOMs and how the market is developing – via social media listening and primary research, including in-depth patient insights.
  • Moving to wider reimbursement, the outcomes trials demonstrating the wider health benefits of AOMs, the prospect of oral agents and new competitors - what will be the key battlegrounds for the Obesity market in coming years?
  • Considering the rapid evolution of market dynamics, succeeding in obesity requires in-depth market understanding and continuous monitoring of core KPI’s. IQVIA’s new syndicated integrated performance tracking solution monitors these KPI’s using market research, real world data and social media metrics. This data is integrated at source to provide the most robust and nuanced insights available to the market.

Related solutions

Contact Us